SIC
CHRS icon

SJS Investment Consulting’s Coherus Oncology CHRS Stock Holding History

SJS Investment Consulting’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703 Buy
502
+395
+369% +$645 ﹤0.01% 2142
2026
Q1 		$181 Buy
107
+19
+22% +$34 ﹤0.01% 2004
2025
Q4 		$125 Buy
+88
New +$128 ﹤0.01% 1921

Other funds holding CHRS

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return

SJS Investment Consulting's CHRS Position: Q2 2026 in Review

SJS Investment Consulting increased its Coherus Oncology (CHRS) stake by 369% in Q2 2026, buying an estimated $645 and bringing the position to 502 shares worth $703. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

SJS Investment Consulting first reported a position in CHRS in Q4 2025 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • SJS Investment Consulting held 502 shares of Coherus Oncology worth $703 as of Q2 2026.
  • SJS Investment Consulting bought 395 Coherus Oncology shares in Q2 2026, an estimated $645.
  • Coherus Oncology made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2142 holding.
  • SJS Investment Consulting first reported a position in Coherus Oncology in Q4 2025 and has held it in 3 quarters since.
  • 25 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.